Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA
Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA
Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA
Submitted by
admin
on June 1, 2015 - 12:18pm
Source:
Fierce Pharma Marketing
News Tags:
Valeant Pharmaceuticals
DTC
Xifaxan
Actavis
IBS
Viberzi
Headline:
Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA
Do Not Allow Advertisers to Use My Personal information
